Riqicef-250 Injection

Riqicef-250 Injection is a sterile Ceftriaxone Injection I.P. 250 mg formulation indicated for the treatment of a wide range of susceptible bacterial infections. As a third-generation cephalosporin antibiotic, it offers broad-spectrum antibacterial activity against respiratory, urinary, skin, soft tissue, bone, joint, abdominal, and bloodstream infections. Suitable for intramuscular and intravenous administration, Riqicef-250 Injection provides effective systemic antibacterial therapy when administered under the supervision of a qualified healthcare professional.

Category:

Description

Ceftriaxone Injection I.P. 250 mg

Riqicef-250 Injection is a sterile Ceftriaxone Injection I.P. 250 mg formulation intended for intravenous (I.V.) or intramuscular (I.M.) administration. Ceftriaxone is a third-generation cephalosporin antibiotic that provides broad-spectrum antibacterial activity against a wide range of susceptible Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, resulting in the elimination of infection-causing bacteria.

Riqicef-250 Injection is commonly prescribed for the treatment of bacterial infections affecting the respiratory tract, urinary tract, skin and soft tissues, bones and joints, abdomen, bloodstream, and central nervous system. It may also be used in certain surgical settings for the prevention of postoperative infections when recommended by a healthcare professional. As an injectable antibiotic, it should be administered only by qualified medical personnel and used only for infections caused or strongly suspected to be caused by susceptible bacteria.

Key Benefits

  • Broad-spectrum third-generation cephalosporin antibiotic.
  • Effective against a wide range of susceptible bacterial infections.
  • Suitable for both intravenous and intramuscular administration.
  • Provides reliable antibacterial coverage in hospitalized and outpatient settings.
  • Sterile injectable formulation for rapid systemic action.
  • Can be used in pediatric and adult patients as prescribed by a healthcare professional.

Composition

Each vial contains:

  • Ceftriaxone Injection I.P. 250 mg (as Ceftriaxone Sodium)

Indications

Recommended for the treatment of susceptible bacterial infections, including:

  • Lower and upper respiratory tract infections
  • Ear, nose, and throat infections
  • Urinary tract infections
  • Skin and soft tissue infections
  • Bone and joint infections
  • Intra-abdominal infections
  • Septicemia (bloodstream infections)
  • Bacterial meningitis
  • Surgical infection prophylaxis, where appropriate

Directions for Use

Reconstitute with the appropriate diluent as directed and administer only by I.M. or I.V. injection under the supervision of a qualified healthcare professional. Dosage and duration of treatment should be determined by the treating physician based on the type and severity of the infection.

Storage

  • Store below 25°C in a cool and dry place.
  • Protect from light.
  • Use the reconstituted solution according to the product instructions.
  • Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “Riqicef-250 Injection”

Your email address will not be published. Required fields are marked *